Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher

Published 08/01/2024, 17:22
Updated 08/01/2024, 18:40
© Reuters.  Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher
CL
-
AMBA
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 1% on Monday.

The Dow traded down 0.19% to 37,396.28 while the NASDAQ rose 1.20% to 14,698.88. The S&P 500 also rose, gaining, 0.55% to 4,722.93.

Check This Out: Don't Miss These 3 Consumer Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts

Leading and Lagging Sectors

Information technology shares jumped by 2% on Monday.

In trading on Monday, energy shares fell by 2.2%.

Top Headline

Commercial Metals Company (NYSE: CMC) posted upbeat earnings for its first quarter on Monday.

Commercial Metals posted adjusted earnings of $1.63 per share, beating market estimates of $1.45 per share. The company’s quarterly sales came in at $2.00 billion versus estimates of $1.89 billion.

Equities Trading UP

Harpoon Therapeutics, Inc. (NASDAQ: HARP) shares shot up 112% to $22.40 after Merck announced it will acquire the company for $23 per share in cash.

Shares of Ambrx Biopharma Inc. (NASDAQ: AMAM) got a boost, surging 100% to $27.32 after Johnson & Johnson announced it will acquire the company in an all-cash merger for a total equity value of approximately $2 billion.

Spectaire Holdings Inc. (NASDAQ: SPEC) shares were also up, gaining 43% to $2.41.

Equities Trading DOWN

LumiraDx Limited (NASDAQ: LMDX) shares dropped 43% to $0.0195. LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th.

Shares of Dada Nexus Limited (NASDAQ: DADA) were down 37% to $1.9999. Dada Nexus said in the course of its routine internal audit, certain suspicious practices were identified that may cast doubt on certain revenues from the company's online advertising and marketing services in 2023.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Solo Brands, Inc. (NYSE: DTC) was down, falling 38% to $3.6850 after the company lowered full year 2023 revenue guidance below estimates.

Also Check This Out: Cramer Says This Major Healthcare Stock Is 'Ridiculously Cheap And Doing So Many Great Things'

Commodities

In commodity news, oil traded down 4.9% to $70.23 while gold traded down 0.6% at $2,038.30.

Silver traded up 0.3% to $23.38 on Monday while copper rose 0.3% to $3.8190.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.38%, London’s FTSE 100 rose 0.06% while Spain’s IBEX 35 Index rose 0.44% The German DAX rose 0.74% French CAC 40 rose 0.40% while Italy’s FTSE MIB Index rose 0.42%.

The consumer confidence indicator in the Eurozone increased by 1.9 points from the prior month to -15 in December, while economic sentiment indicator climbed to 96.4 in December from the revised reading of 94.0 in the earlier month. Retail sales in the Eurozone fell by 0.3% from the prior month in November versus a revised 0.4% increase in October.

Factory orders in Germany increased by 0.3% month-over-month in November, while Germany's trade surplus widened to EUR 20.4 billion in November versus a revised EUR 17.7 billion in the prior month.

Asia Pacific Markets

Asian markets closed lower on Monday, with Hong Kong’s Hang Seng Index falling 1.88% and China’s Shanghai Composite Index falling 1.42%. India’s S&P BSE Sensex, meanwhile, fell 0.93%.

Chinese foreign exchange reserves increased to $3.238 trillion in December from $3.172 billion in the prior month.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Economics

Data on consumer credit for November will be released at 3:00 p.m. ET.

Now Read This: How To Earn $500 A Month From Acuity Brands Stock Ahead Of First-Quarter Earnings Report

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.